Psilocybin and Consciousness

The Default Mode Network and Psilocybin

The default mode network (DMN) is a set of interconnected brain regions — including the medial prefrontal cortex, posterior cingulate cortex, and angular gyrus — that are most active during self-referential thought, mind-wandering, and autobiographical memory retrieval. Neuroscientists regard the DMN as a central substrate for the ordinary sense of self or "ego." It is characteristically suppressed during focused external tasks and highly active during rest.

In 2012, Robin Carhart-Harris and colleagues at Imperial College London published the first neuroimaging study of psilocybin's effects on the human brain, using arterial spin labelling (ASL) perfusion fMRI. The study, published in PNAS, demonstrated that psilocybin significantly decreased cerebral blood flow and BOLD signal in key DMN hubs — particularly the posterior cingulate cortex and medial prefrontal cortex. Crucially, the degree of DMN suppression correlated with the subjective intensity of ego dissolution reported by participants, establishing a direct neural correlate for one of psilocybin's most characteristic effects.

Ego dissolution — the temporary loss of the ordinary boundary between self and world — is widely reported at higher psilocybin doses. Participants describe a dissolution of personal identity, a merging with the environment, and a sense of unity or oceanic boundlessness. These states, while disorienting to some, are closely associated with long-term positive psychological outcomes in clinical research, suggesting that DMN suppression may be mechanistically important rather than merely incidental.

Neural Correlates of Mystical Experience

Building on the 2012 findings, Carhart-Harris developed the "entropic brain" hypothesis, published in Frontiers in Human Neuroscience (2014). This theory proposes that psychedelics increase the entropy (randomness and complexity) of brain activity, temporarily shifting the brain away from constrained, habitual processing patterns. Under psilocybin, the brain accesses a broader range of functional states, explaining the richness and novelty of psychedelic experience.

A 2019 refinement, the REBUS model (Relaxed Beliefs Under Psychedelics), published by Carhart-Harris and Karl Friston in Pharmacological Reviews, integrated predictive coding theory. REBUS proposes that the brain normally operates as a "prediction machine" in which high-level beliefs — encoded in the DMN — constrain and dampen lower-level sensory signals. Psilocybin, by suppressing top-down DMN activity via 5-HT2A receptor agonism on cortical layer V pyramidal neurons, "relaxes" these hierarchical constraints. The result is that bottom-up sensory and emotional signals gain unusual influence, producing vivid perceptions, novel associations, and mystical experiences of unity and insight.

EEG studies complement fMRI data by revealing psilocybin's effects on oscillatory brain activity. Research has documented decreases in alpha-band power (8–12 Hz) — a signature of relaxed, inwardly focused attention — and increases in neural signal diversity measurable through Lempel-Ziv complexity. These findings provide converging evidence that psilocybin genuinely increases the information content of neural activity rather than simply causing non-specific arousal.

Consciousness Research Implications

Altered states of consciousness have long been of interest to philosophers and neuroscientists, but ethical and logistical barriers historically limited rigorous study. Psilocybin provides a reproducible, dose-controllable, and reversible means of inducing profoundly altered states, making it an invaluable research tool for consciousness science. Studies can now test hypotheses about the neural basis of self-awareness, temporal perception, and subjective experience with a precision previously impossible.

Long-term personality changes following psilocybin experiences provide another dimension of scientific interest. Roland Griffiths and colleagues at Johns Hopkins University (2006, Psychopharmacology) documented that single high-dose psilocybin sessions reliably produced "complete mystical experiences" in 61–83% of participants, and that 14 months later, participants rated the experience among the most personally meaningful of their lives. A 2011 follow-up by Katherine MacLean and colleagues found significant increases in the personality trait "openness to experience" — one of the Big Five personality dimensions — that persisted over a year, a finding remarkable because adult personality traits are generally considered stable.

Neuroimaging research has also documented lasting changes in brain connectivity following psilocybin. A 2014 study by Petri et al. in Journal of the Royal Society Interface used network analysis to show that psilocybin transiently creates novel functional connectivity patterns not seen in normal waking consciousness, including links between brain regions that do not normally communicate. These temporary "connectome" changes may underlie the formation of new insights and perspectives that outlast the acute experience.

Therapeutic Relevance of Consciousness Changes

The therapeutic implications of psilocybin's effects on consciousness are significant. Carhart-Harris and colleagues proposed the "reset hypothesis" in 2017, based on their open-label trial of psilocybin in 20 patients with treatment-resistant depression, published in Scientific Reports. They observed that psilocybin rapidly reduced depressive symptoms — in some cases within 24 hours — and that post-treatment brain scans showed normalisation of previously hyperactive amygdala responses to negative stimuli. The idea is that depression involves rigid, self-referential rumination enforced by an overactive DMN, and that psilocybin temporarily disrupts these entrenched patterns, allowing the brain to "reset" to more flexible functioning.

This framework aligns with the clinical observation that the quality of the psychedelic experience predicts therapeutic outcome. Participants who report more complete mystical experiences — characterised by feelings of unity, sacredness, noetic quality, and deeply felt positive affect — tend to show the greatest reductions in depression, anxiety, and substance use. This suggests that the subjective phenomenology of consciousness change is not merely epiphenomenal but may be mechanistically involved in therapeutic benefit, whether through emotional processing, shifts in self-perception, or neuroplastic consolidation of new cognitive patterns.

Frequently Asked Questions

What is the default mode network?

The default mode network (DMN) is a set of brain regions — including the medial prefrontal cortex, posterior cingulate cortex, and angular gyrus — that are most active during self-referential thought, daydreaming, and autobiographical memory. It is considered a key neural substrate of the ordinary sense of "self" or ego.

What did Carhart-Harris's 2012 study find?

The 2012 Imperial College London study found that psilocybin significantly decreased blood flow and neural activity in key DMN hubs, particularly the posterior cingulate cortex. Importantly, the degree of DMN suppression correlated with the intensity of ego dissolution that participants reported, establishing a direct neural correlate of this subjective state.

What is ego dissolution?

Ego dissolution is the temporary loss of the ordinary sense of self — the feeling that the boundary between "me" and the external world has dissolved. It is commonly reported at higher psilocybin doses and is associated with feelings of unity, oceanic boundlessness, and at higher intensities, the complete absence of a subject-object distinction.

What is the REBUS model?

REBUS (Relaxed Beliefs Under Psychedelics) is a theoretical model published in 2019 by Carhart-Harris and Friston. It proposes that the brain normally uses high-level beliefs encoded in the DMN to suppress lower-level sensory signals. Psilocybin relaxes this top-down suppression, allowing bottom-up signals to dominate — producing vivid perceptions, novel associations, and mystical experience.

Does psilocybin permanently change the brain?

The acute effects of psilocybin fully resolve within 4–6 hours. However, some studies document lasting changes: increased "openness to experience" personality scores (MacLean et al. 2011) and altered functional connectivity patterns. These appear to reflect psychological and synaptic reorganisation rather than structural damage, and clinical evidence suggests these changes can be beneficial.

What is the entropic brain hypothesis?

The entropic brain hypothesis (Carhart-Harris 2014) proposes that psychedelics increase the entropy — the randomness and informational complexity — of brain activity. This temporarily shifts the brain toward less constrained, more flexible processing, which explains the novelty, creativity, and richness of psychedelic experience.

How is psilocybin research relevant to understanding consciousness?

Psilocybin provides a reproducible, dose-controlled, reversible means of altering consciousness in the laboratory. This allows scientists to test theories about the neural correlates of self-awareness, temporal perception, and subjective experience that are otherwise extremely difficult to study. It is one of the most powerful tools available in consciousness research.

What is the "reset hypothesis" for depression?

The reset hypothesis (Carhart-Harris et al. 2017) proposes that depression involves rigid, self-referential rumination sustained by an overactive DMN. Psilocybin temporarily disrupts these entrenched neural patterns, allowing the brain to reorganise into healthier functional states — akin to "switching off and on again." Post-treatment brain scans in treatment-resistant depression patients showed normalisation of previously hyperactive amygdala responses.

Does the quality of the psychedelic experience matter for therapy?

Yes — research consistently shows that participants who report more complete mystical experiences during psilocybin sessions achieve the greatest therapeutic benefits for depression, anxiety, and addiction. This suggests the subjective phenomenology of consciousness change is mechanistically involved in healing, not merely incidental to it.

Can psilocybin cause lasting harm to consciousness or personality?

No persistent adverse effects on cognition or personality have been documented in controlled clinical research with appropriate screening and set/setting. The documented personality changes — increased openness — are viewed as positive by participants and researchers alike. However, in vulnerable individuals or unsupported settings, psychologically difficult experiences can occur, which is why clinical research relies on careful screening and trained facilitators.